TokenPost·
Agenus Reports 72% Pathologic Complete Response in dMMR Colon Cancer Cohort
72%
complete response rate
The 18-patient Phase 2 cohort also met the study’s primary major pathologic response measure in 83% of patients.
More news
- TokenPostBitcoin Topped $80,000 at $80,014 on Binance Spot at 7:46 p.m. ET Sunday
- Crypto BriefingSolana adds $22M in euro stablecoins in one week, outpacing every other chain
- TokenPostTexas Regulator Says Filing System Is Temporarily Down for Data Center Review
- Bitcoin.com NewsBank of Israel Rejects Netanyahu’s Crypto Sanction-Evasion Plan
- TokenPostDucat Wallet Supports Turbo UNIT Cashu Transfers on Mutinynet
- TokenPostBitcoin Falls Below the $80,000 Level During the Trading Session